QIAGEN Announces Supply Agreement to Provide Preanalytical Solutions to Osmetech Molecular Diagnostics
22 Nov 2005 -
QIAGEN GmbH, a wholly-owned subsidiary of QIAGEN N.V. and Osmetech Molecular Diagnostics., a division of Osmetech plc announced that they have entered into a distribution agreement. Pursuant to this agreement, Osmetech will incorporate certain preanalytical consumables and technologies from QIAGEN into Osmetech microarray-based solutions for use in diagnostic and research applications. QIAGEN's proprietary
preanalytical technologies provide unmatched reproducibility and efficiency in molecular diagnostics applications.